Emron Managed Care News 8-7-15

New cocktails to test limits of cancer drug pricing New cancer drug cocktails set to reach the market in the next few years will test the limits of premium pricing for life-saving medicines, forcing company executives to consider fresh market strategies. http://reut.rs/1P05keX   ACOs Appear Unable to Incentivize Physicians to Limit Costs Practices in affordable … Continued

Emron Managed Care News 6-26-15

  A year after VA scandal, little progress on wait-lists One year after reports of long wait-list and cover-ups of care delays rocked the U.S. Department of Veterans Affairs (VA), not only have wait-lists only grown longer, but a budget shortfall of nearly $3 billion could affect care for many veterans, according to a report in The New York Times. … Continued

Emron Managed Care News 6-12-15

More flexibility, options under Medicare ACO final rule http://bit.ly/1dqiuVg For the most part, industry experts are pleased with the changes the Centers for Medicare & Medicaid Shared  Savings Program (MSSP), which provides more options and opportunities for accountable care organizations (ACOs) to participate in the risk-based shared savings initiative. The 5 most common medications in the US … Continued

Emron Managed Care News 5-29-15

Too Many Women Who Need Bone Screening Aren’t Getting It http://bit.ly/1Hu5YM2 Too few womens at high risk for osteoporosis are being tested for the bone-depleting condition, while too many women at low-risk are being screened, a new study suggests.   Boehringer Ingelheim’s combination COPD therapy Stiolto Respimat garners FDA approval http://bit.ly/1Hu8e61 Boehringer Ingelheim announced Tuesday that the FDA approved … Continued

Emron Managed Care News 5-22-15

Combination Treatment for Cystic Fibrosis Shows Promise Combining two medications that target the most common genetic cause of cystic fibrosis improved lung function in people with the disease. The combination therapy also reduced the rate of lung infections and other problems, according to a new study. Prostate Cancer Testing Drops Off After Controversial Guidelines Fewer … Continued

Emron Managed Care News 5-15-15

Emron Managed Care News Blood Thinner Warfarin May Pose Greater Bleeding Risk for Obese: Study Obese patients taking the blood thinner warfarin appear to have almost twice the risk of severe stomach bleeding compared to their normal-weight counterparts, a new study suggests. Medicaid Expansion Is Still A Tumultuous Fight In Several States Five years after the Affordable Care Act passed, … Continued

Emron Managed Care News 5-8-15

FDA clears The Medicines Company’s Raplixa, Ionsys The FDA approved The Medicines Company’s Raplixa (fibrin sealant) as the first spray-dried fibrin sealant cleared in the US to help control bleeding during surgery, the company announced. The biological product is approved for use in adults to help control bleeding from small blood vessels when standard surgical … Continued